Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

336.07 -6.33 (-1.85%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

61 62 Next >

Check Out What Whales Are Doing With AMGN ↗

September 29, 2023

Via Benzinga

AskSlim Market Week - Friday, Sep. 29 ↗

September 29, 2023

Technical and cycle analysis, and market commentary.

Via Talk Markets

3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals ↗

September 28, 2023

The demand for biotech stocks is intense and is likely to only greatly increase going forward, especially in the United States.

Via InvestorPlace

September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average ↗

September 27, 2023

The September market downturn is spreading like wildfire across various sectors, with only a handful of stocks managing to maintain the positive trend seen in recent months.

Via Benzinga

Topics Stocks

FDA Strikes Off Coherus BioSciences' New Injector Biosimilar Treatment For Cancer Patients ↗

September 25, 2023

The FDA issued a Complete Response Letter regarding the Biologics License Application supplement for Udenyca Onbody, Coherus BioSciences Inc's (NASDAQ: CHRS) on-body injector (OBI) presentation of...

Via Benzinga

2 Dividend Growth Stocks to Buy Right Now ↗

September 21, 2023

A wise man once said, be greedy when others are fearful.

Via The Motley Fool

Check Out What Whales Are Doing With AMGN ↗

September 20, 2023

Via Benzinga

Amgen Unusual Options Activity ↗

September 15, 2023

Via Benzinga

Argenx's 28% Surge & Promising Product Propel Investor Confidence

September 25, 2023

Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target.

Via MarketBeat

AI To Revolutionize Clinical Trials And Diagnostics ↗

September 22, 2023

With the help of technology, the pharmaceutical industry is gaining new insights that are fueling the development of next generation of drugs while also speeding up clinical trials and improving...

Via Benzinga

Topics Artificial Intelligence

Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty

September 22, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal,...

Via FinancialNewsMedia

$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today ↗

September 13, 2023

Via Benzinga

2 Top Dividend Stocks to Buy in September ↗

September 13, 2023

These two blue-chip dividend stocks have stood the test of time.

Via The Motley Fool

How Is The Market Feeling About Amgen? ↗

September 08, 2023

Via Benzinga

From Years to Months: How AI is Shaping the Landscape of Clinical Trials ↗

September 22, 2023

Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significant sums of money. These...

Via Benzinga

Topics Artificial Intelligence

Why Shares of Neumora Therapeutics Slumped This Week ↗

September 21, 2023

The clinical-stage biotech just had its IPO last week.

Via The Motley Fool

Topics Initial Public Offering

Flee to Healthcare Stocks if Recession Rears its Head?

September 20, 2023

In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.

Via MarketBeat

Topics Economy

3 Quality Dividend Stocks For A Bear Market ↗

September 14, 2023

The potential for a recession means investors should focus on quality dividend stocks with strong yields.

Via Talk Markets

Topics Economy

These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts ↗

September 13, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

8 Analysts Have This to Say About Amgen ↗

September 05, 2023

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy in September 2023 ↗

September 12, 2023

While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.

Via InvestorPlace

Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis ↗

September 11, 2023

Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has

Via Benzinga

Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market ↗

September 11, 2023

Advancements in healthcare and medicine have helped contribute to the reduction in child mortality rates, plummeting from 185 per 1,000 births a century ago to just 7 per 1,000 births in 2020. However,...

Via Benzinga

3 Growth Stocks to Buy in September

September 06, 2023

As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earnings

Via MarketBeat

Topics Economy

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗

September 06, 2023

Via Benzinga

Amgen's Horizon Acquisition Offers Multiple Advantages: Tax Breaks, Shield From Drug Pricing Negotiations ↗

September 05, 2023

On Friday, the U.S.

Via Benzinga

Should You Still Buy the Dow Jones' Best-Performing August Stocks? ↗

September 05, 2023

They're rolling now, but this market has been too hot-and-cold of late to ignore any company's -- or company's stock's -- underlying bigger picture.

Via The Motley Fool

Topics Stocks

The 3 Most Promising Dow Stocks to Own Now ↗

September 03, 2023

The Dow market leaders got their heads handed to them in August. Here are three must-own Dow stocks to own for the long haul.

Via InvestorPlace

Topics Stocks

8 Pharma Stocks Affected by New Drug Price Negotiation Rules ↗

September 02, 2023

Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?

Via The Motley Fool

Stock Market Rally Gains Momentum As Treasury Yields Slide; Tesla Unveils Model 3 Upgrade: Weekly Review ↗

September 01, 2023

Tesla unveiled an updated Model 3, but also slashed Model S, X prices.

Via Investor's Business Daily

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

61 62 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.